Abstract: Described herein are nutritional supplements containing ?-hydroxy-isocaproic acid and aspartic acid (e.g., DAA) and their methods of use in enhancing muscle performance and/or recovery after exercise. The nutritional supplements can be used to enhance muscle building and lean body mass, enhance muscle and physical performance, enhance recovery, and prevent catabolism (muscle atrophy or wasting) when administered to a mammalian subject.

Abstract: Described herein are nutritional supplements containing ?-hydroxy-isocaproic acid and aspartic acid (e.g., DAA) and their methods of use in enhancing muscle performance and/or recovery after exercise. The nutritional supplements can be used to enhance muscle building and lean body mass, enhance muscle and physical performance, enhance recovery, and prevent catabolism (muscle atrophy or wasting) when administered to a mammalian subject.

Abstract: This invention pertains to method and compositions for the purpose of increasing serum level of Erythropoietin (EPO) and the subsequent increase of red blood cells leading to an increase in athletic endurance.

Abstract: A method of enhancing regional body fat reduction is disclosed. The method includes topically applying a fat reduction topical composition on a region of a human body where a regional fat reduction is desired for a treatment period, and administering an amount of a fat reduction oral composition daily during the treatment period. The topical composition includes hydroglycolic fluid extract of Palmaria palmata, Laminaria digitata extract, mannitol, and a pharmaceutically acceptable carrier. The oral composition includes synephrine, methylxanthine, chromium, a herbal combination having diuretic effect and a pharmaceutically acceptable carrier.

Abstract: A dietary supplement system having a daytime component and a nighttime component is provided, wherein the daytime component comprises at least one thermogenic substance and the nighttime component comprises at least one adrenal support substance.